Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients

BACKGROUND: Prostate cancer (PCa) is one of the most common cancers among men worldwide. Current screening methods for PCa display limited sensitivity and specificity, not stratifying for disease aggressiveness. Hence, development and validation of new molecular markers is needed. Aberrant gene prom...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreira-Barbosa, Catarina, Barros-Silva, Daniela, Costa-Pinheiro, Pedro, Torres-Ferreira, Jorge, Constâncio, Vera, Freitas, Rui, Oliveira, Jorge, Antunes, Luís, Henrique, Rui, Jerónimo, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206889/
https://www.ncbi.nlm.nih.gov/pubmed/30373654
http://dx.doi.org/10.1186/s13148-018-0564-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206889/
https://www.ncbi.nlm.nih.gov/pubmed/30373654
http://dx.doi.org/10.1186/s13148-018-0564-2

Ejemplares similares